Open Access
ARTICLE
Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumab
1 Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
2 Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
3 Department of Hematology-Oncology, Ajou University School of Medicine, Suwon-si, Gyeonggi-do, Korea
4 Samsung Advanced Institute of Health Science and Technology, Sungkyunkwan University School of Medicine, Seoul, Korea
* Corresponding Authors: SUNG HEE LIM. Email: ; SEUNG TAE KIM. Email:
# These authors contributed equally